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ABSTRACT 
Vernonia amygdalina has been a known food and medicinal plants used in Asia and 
Africa (West Africa) due to its pharmacological effects (antioxidant, anti-diabetes, anti-
inflammatory, anticancer, anti-malaria, and among others). The phytochemical studies 
revealed that this plant is enriched with proteins, fats, fibres, amino acids, minerals, 
vitamins, and carbohydrates. Many bioactive compounds had been isolated from its 
extracts. Therefore, this review summarized the overview of the bioactive compounds, 
phytochemical and pharmacological properties of V. amygdalina as well as its 
mechanism of action and toxicology. 
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1.0 INTRODUCTION 
Bitter leaf (Figure 1) scientifically known as V. amygdalina is one of the most famous 
plants found in Africa and Asia. It is the most cultivated species of the genus Vernonia 
that is about 1,000 species of shrub (Njan et al., 2008; Agbogidi and Akpomorine, 
2013; Toyang and Verpoorte, 2013; Egharevba et al., 2014). V. amygdalina has been 
the most prominent species in the family of Asteraceae that had been studied in Africa 
(Ankit et al., 2010; Nwaoguikpe, 2010; Farombi and Owoeye, 2011; Ijeh and Ejike, 
2011). Normally, V. amygdalina does not produce seeds but its cultivation is usually 
done by stem planting and mostly grow in tropical areas. This plant is found majorly 
along the drainage, commercial plantation or forest (Yeap et al., 2010).  
 
V. amygdalina is a wooded shrub of about 2 to 10 m height that regenerates rapidly after 
planted. The leaves are petiolated in shape with a bitter taste of which its name “Bitter 
leaf” spring up. V. amygdalina are being called different local names which vary from 
country to country (Table 1). The bitter taste had been associated with the presence of 
saponins, alkaloids, tannins, and glycosides. These made them act as a bittering agent 
and a hop substitute used for controlling microbial contamination in beer brewing 
without reducing the quality of malt (Ayoola et al., 2008; Ankit et al., 2010; Adama et 
al., 2011; Farombi and Owoeye, 2011).This plant can be harvested twice per month for 
the period of seven years. They are popularly used for food and traditional medicine, 
their characteristic odour and bitter taste can be reduced either by washing in several 
changes of water or by boiling before consumption (Nwaoguikpe, 2010; Agbogidi and 
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Akpomorine, 2013; Toyang and Verpoorte, 2013; Alara et al., 2017a). The Medical 
Traditional Healer Association in Rukararwe, Uganda produced the greenish powder 
packed in sachet and consume as tea by patients suffering from malaria (Njan et al., 
2008), it has also been reported to be used in soup (Ogbono and Orugbo soups) in 
Nigeria and Cameron (Ndole dish) (Yeap et al., 2010; Oduah, 2012; Agbogidi and 
Akpomorine, 2013; Oguwike et al., 2013). The honey wine called Tei are being 
produced from the bitter leaf in Ethiopia (Yeap et al., 2010). The leaves and roots 
decoctions have been used in ethnomedicine to treat hiccups, fevers, kidney problems 
and stomach disorder (Igile et al., 1994; Yeap et al., 2010; Sha, 2011; Oduah, 2012). 
Several studies carried out on this plant had suggested that it contains different bioactive 
compounds, including, flavonoids, saponins, alkaloids, tannins, phenolics, terpenes, 
steroidal glycosides, triterpenoids, and several types of sesquiterpene lactones (Erasto et 
al., 2006; Farombi and Owoeye, 2011; Kiplimo et al., 2011; Toyang and Verpoorte, 
2013; Adedapo et al., 2014; Quasie et al., 2016; Luo et al., 2017). These bioactive 
compounds made them possess different pharmacological properties like antimicrobial, 
antimalarial, antithrombotic, antioxidant, anti-diabetic, laxative, hypoglycemic, 
antihelmintic, anti-inflammatory, cathartic, anticancer, antifertility, anti-fungi, 
antibacterial, and among others (Igile et al., 1994; Akinpelu, 1999; Iwalokun et al., 
2006; Erasto et al., 2007; Gresham et al., 2008; Khalafalla et al., 2009; Ilondu, 2010; 
Farombi and Owoeye, 2011; Anibijuwon et al., 2012; Ngatu et al., 2012; Adetunji et 
al., 2013; Atangwho et al., 2013; Akinyele et al., 2014; Ezeadila et al., 2015; 
Udochukwu et al., 2015; Alara et al., 2017c). 
The objective of this review paper is to outline and discuss the studies that had been 
done on the bioactive compounds, phytochemical and pharmacological properties of V. 
amygdalina. Besides, this review also expatiates the mechanism of action and 
toxicological effects of V. amygdalina extracts. 
 
 
Figure 1: Vernonia amygdalina  
Source: (Yeap et al., 2010) 
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Table 1: Different local names of Vernonia amygdalina 
Country Local name(s) 
English Bitter leaf 
Tanzania Omjunso 
Nigeria Onugbo, Ewuro, Etidot, 
Ityuna, Oriw, Chusa-doki 
Shiwaka 
Malaysia South Africa leaf 
Rwanda Umubilizi 
Cameron Suwaaka 
Uganda Labwori, Omubirizi, 
Ekibirizi 
Ghana Awonoo, Awonwene, 
Jankpantire 
Congo Mpasi nyioso 
Zimbabwe Musikavakadzi 
Gabon Ndoki 
China Ikaruga 
Kenya Olulusia 
Ethiopia Grawa, Graw 
Source: (Igile et al., 1994; Alabi et al., 2005; Iwalokun et al., 2006; Njan et al., 2008; 
Nwaoguikpe, 2010; Akpaso et al., 2011; Farombi and Owoeye, 2011; Owen, 2011; 
Oduah, 2012; Toyang and Verpoorte, 2013; Egharevba et al., 2014) 
 
2.0 PHYTOCHEMICAL PROPERTIES OF V. amygdalina 
Nutritional Value 
The analysis had shown that V. amygdalina leaves, stems, and root is enriched with 
proteins, fats, fibres, amino acids, minerals vitamins, and carbohydrates (Igile et al., 
1994; Alabi and Amusa, 2005; Owu et al., 2008). The nutritional compositions of V. 
amygdalina leaf, root and stems varied from one study to another, probably due to 
different geographical location, genetic, environmental, harvest conditions, and ecology 
of the plant. Early studies reported that V. amygdalina leaves contain carbohydrates 
(4.31 mg/100 g), proteins (20.2 mg/100 g), lipids (15.0 mg/100 g), acids (10.26 mg/100 
g), iodine (35.82 mg/100 g), hydrocyanic acid (0.46 mg/100 g), total oxalate (0.62 
mg/100 g), amino acid, viz: thiamine (170 mg/100 g), pyridoxine  (2.6 mg/100 g), 
ascorbic acid (20.49 mg/100 g), glycine (4.63 mg/100 g), cysteine (1.84 mg/100 g), 
casein hydrolysate (96.99 mg/100 g), nicotinamide (1.65 mg/100 g). In another study, 
there was a variation in the nutritional values of V. amygdalina leaf, stem and root as 
summarized in Table 2. 
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Table 2: V. amygdalina leaves chemical and nutritional compositions 
Leaf  Stem  Root 
Composition 
(mg/100 g dry 
weight) 
Value  Composition per 
100 g dry weight 
Value  Composition per 
100 g dry weight 
Value 
Sugar contents   Vitamins and 
minerals 
  Vitamins and 
minerals 
 
Glucose 7.20  Vitamin A 
(mg/100 g) 
21.5  Vitamin A 
(mg/100 g) 
30.90 
Sucrose 13.20  Vitamin C 
(mg/100 g) 
49.0  Vitamin C 
(mg/100 g) 
10.30 
Fructose 6.00  Vitamin E 
(mg/100 g) 
106.20  Vitamin E 
(mg/100 g) 
35.83 
Lactose 2.61  Thiamin (mg/100 
g) 
0.50  Thiamin (mg/100 
g) 
0.37 
Galactose 6.56  Riboflavin 
(mg/100 g) 
0.13  Riboflavin 
(mg/100 g) 
0.15 
Arabinose 9.25  Niacin (mg/100 g) 0.03  Niacin (mg/100 g) 0.05 
Raffinose 5.10  Saponins (%) 13.21  Saponins (%) 28.52 
Maltose 
 
7.24  Alkaloid (%) 7.02  Alkaloid (%) 6.11 
Mineral ash 
and fibre 
content                                                      
  Flavonoid (%) 1.02  Flavonoid (%) 0.51 
Na 8.48  Fe (mg/100 g) 0.12  Fe (mg/100 g) 0.09 
Ca 67.39  Cu (mg/100 g) 0.021  Cu (mg/100 g) 0.022 
K 60.90  Zn (mg/100 g) 0.14  Se (mg/100 g) 0.016 
P 60.90  Proximate values   Zn (mg/100 g) 0.26 
Mg 88.10  Crude fat (%) 34.03   
Proximate values 
 
Mn 5.56  Moisture (%) 18.50  Crude fat (%) 30.15 
Fe 14.20  Crude protein (%) 6.71  Moisture (%) 12.00 
Cu 6.01  Ash (%) 17.99  Crude protein (%) 7.30 
Zn 8.05  - -  Ash (%) 11.01 
Ash 10.22  - -  - - 
Fibre 9.75  - -  - - 
 
Vitamins and 
amino acids 
  - -  - - 
Polyphenols 
(mg/100 g) 
9.75  - -  - - 
Vitamin C 
(mg/100 g) 
228.40  - -  - - 
Vitamin A 
(IU/100g) 
345.50  - -  - - 
Vitamin E 
(IU/100g) 
37.30  - -  - - 
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Vitamin B1 
(%) 
1.00  - -  - - 
Vitamin B2 
(mg/100g) 
3.10  - -  - - 
Niacin 0.41  - -  - - 
Oxalic acid 
(mg/100 g) 
5.36  - -  - - 
Carotenoids 
(mg/100 g) 
30.00  - -  - - 
Saponins 
(mg/100 g) 
1.425  - -  - - 
Ihiamine 
(mg/100 g) 
170.00  - -  - - 
Pyrdoxine 
(mg/100 g) 
2.06  - -  - - 
Glycine 
(mg/100 g) 
4.63  - -  - - 
Cysteine 
(mg/100 g) 
1.84  - -  - - 
Casein 
hydrolysate 
(mg/100 g) 
96.99  - -  - - 
Nicotinamide 
(mg/100 g) 
1.65  - -  - - 
Average 
nutritive value 
 
1.10  - -  - - 
Proximate 
values 
  - -  - - 
Digestible 
protein (g) 
16.58  - -  - - 
Moisture (%) 79.92  - -  - - 
Crude protein 
(g) 
19.23  -   - - 
Total 
carbohydrate 
(g) 
68.35  - -  - - 
Total lipids 4.70  - -  - - 
Reducing 
sugar (g) 
14.31  - -  - - 
Dry matter 
(%) 
20.08  - -  - - 
Ash (g) 7.72  - -  - - 
Dietary fibre 
(g) 
25.47  - -  - - 
Energy (Kcal) 392.67  - -  - - 
Total oxalate 
(mg/100g) 
0.62  - -  - - 
Iodine 35.82  - -  - - 
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(mg/100g)  
Source: (Alabi and Amusa, 2005; Alabi et al., 2005; Nwaoguikpe, 2010; Eyong et al., 
2011; Toyang and Verpoorte, 2013) 
 
Bioactive Compounds in Vernonia amygdalina 
Several studies had been done in isolating and characterizing some bioactive 
compounds from V. amygdalina. The phytochemical studies had resulted in the isolation 
of flavonoids, saponins, alkaloids, tannins, phenolics, terpenes, steroidal glycosides, 
triterpenoids, and several types of sesquiterpene lactones (Erasto et al., 2006; Farombi 
and Owoeye, 2011; Kiplimo et al., 2011; Toyang and Verpoorte, 2013; Adedapo et al., 
2014; Quasie et al., 2016; Luo et al., 2017). Figure 2 shows some of the isolated 
bioactive compounds reported in the literature.  Sesquiterpene lactones (vernodalinol, 
vernolepin, vernomygdin, hydroxyvernolide, vernolide and vernodalol) had been 
reported to inhibit breast cancer cell growth, possessed antitumoral and antimicrobial 
properties, and exhibited a significant bactericidal activity against gram bacteria (Jisaka 
et al., 1993; Erasto et al., 2006; Amodu et al., 2013; Luo et al., 2017). Isolated 
vernoniosides from V. amygdalina leaves exhibited anti-inflammatory property and 
used in the treatment of gastrointestinal disorder when tested with murine macrophage 
cell line and wild chimpanzees, respectively (Huffman et al., 1993; Quasie et al., 2016). 
Flavonoids, tannins, saponins, and triterpenoids had been studied to possess antioxidant 
and hypolipidaemic effects (Igile et al., 1994; Erasto et al., 2007; Ayoola et al., 2008; 
Farombi and Owoeye, 2011; Atangwho et al., 2013; Alara et al., 2017b). 
 
                     
Luteolin   Luteolin 7-O-β-glucoside      Luteolin7-O-glucuronide 
(a) 
      
Vernolide         Vernolepin        Vernodalin Hydroxyvernolide 
         
Vernodalol   Vernomygdin    Vernomenin     4,15-dihydrovernodalin 
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1,2,2ʹ,3ʹ-tetrahydrovernodalin    1,2,11,12ʹ,3ʹ-hexahydrovernodalin      Epiverodalol 
    
1,2,4,15,11,13,2ʹ,3ʹ-octahydrovernodalin   Vernonioside A1, A2, A3, A4, B1, B2, B3, 
and B4 
(b) 
                  
Thiamin  Ascorbic acid             Pyridoxine  Glycine 
                   
Cysteine   Casein hydrolysate 
(c) 
Figure 2: Isolated flavonoids (a), sesquiterpenes lactones (b) and triterpenes (c) from V. 
amygdalina (Erasto et al., 2006; Farombi and Owoeye, 2011; Kiplimo et al., 2011; 
Toyang and Verpoorte, 2013; Adedapo et al., 2014; Quasie et al., 2016; Luo et al., 
2017) 
 
Flavonoids 
Flavonoids are a group of natural compounds found in plants with variable phenolic 
structures. They are present virtually in all parts of the plant. Flavonoids are responsible 
for the taste, colour, protection of vitamins and enzymes, and prevention of fat 
oxidation (Yao et al., 2004). The pharmacology importance of flavonoids, including, 
antioxidant, hepatoprotective, antibacterial, anti-inflammatory, anticancer, and antiviral 
activities are indispensable in the human body (Yao et al., 2004; Shashank and Abhay, 
2013). V. amygdalina possesses flavonoids which can be extracted from the leaves 
using organic solvents. Different flavonoids had been isolated from the crude extracts of 
V. amygdalina leaf. In the early study, three flavones (luteolin, luteolin 7-O-β-
glucuronoside and lutelin7-O-β-glucoside) were identified (Figure 2a). The identified 
flavones showed strong antioxidant activities (Igile et al., 1994). Luteolin exhibited 
stronger antioxidant activity in comparison to the synthetic butylated hydroxytoluene 
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(BHT) at 15 mg/l. Besides this, luteolin 7-O-glucuronoside (the most abundant 
compound) and luteolin 7-O-glucoside also possess similar antioxidant activity but 
significantly lower as compared to luteolin. This may be attributed to the blockage of 
glycosides with glucose or uronic acid linked at the 7-O position compared with the 
unsubstituted 5,7- OH of luteolin. Higher antioxidant inhibition was observed in the 
ethanolic extraction of luteolin than aqueous extract (Yeap et al., 2010). This may 
contribute to the higher antioxidant activity of ethanol extract compared to water 
extract. The chemical structures of the isolated flavones are shown in Figure 2a. 
 
Sesquiterpene lactones 
This is another group of phytochemicals isolated from V. amygdalina. Sesquiterpenes 
lactones are secondary metabolites widely found in family Asteraceae. They possess 
pharmacology properties like antibacterial, anaesthetic, antifungal, anti-inflammatory, 
antiprotozoal, and antimicrobial. Most of the isolated sesquiterpene lactones from V. 
amygdalina were from leaf, stem, and root. The isolated compounds were vernolide, 
vernolepin, vernodalin, hydroxyvernolide, vernodalol, vernomygdin, vernomenin, 4,15-
dihydrovernodalin, 1,2,11,12ʹ,3ʹ hexahydrovernodalin, 1,2,4,15,11,13,2ʹ,3ʹ octahydrover
nodalin, epivernodalol, and vernonioside A1, A2, A3, A4, B1, B2, B3, and B4 
(Huffman et al., 1993; Jisaka et al., 1993; Khalafalla et al., 2009; Owoeye et al., 2010; 
Quasie et al., 2016; Luo et al., 2017). The chemical structures of these sesquiterpenes 
lactones are showed in Figure 2b. 
 
Vernodalin and vernolide had been reported to exhibit potent activity (IC50 for P-388 
and L-121O cells: 0.11 and 0.17 µg/ml for vernodalin and 0.13 and 0.11 µg/ml for 
vernolide, respectively), while the activity of hydroxyvernolide and vernodalol was 
weak. The lower activity of hydroxyvernolide, vernolepin and vernodalol could be 
explained by the loss of hydrophobicity in the acyl moiety (Jisaka et al., 1993). In 
another study, vernolide showed a significant inhibition against gram-positive bacteria 
B. cereus, Staphylococcus epidermidus, B. subtilis, S. aureus, M. luteus, M. kristinae, 
and Streptococcus pyrogens and the gram-negative bacterium Salmonella pooni. These 
showed its antibacterial activity (Erasto et al., 2006; Luo et al., 2017). More so, 
vernodalin and vernomygdin had been reported to possess antitumor activity against 
human nasopharynx carcinoma KB, L-1210 cancer cell lines and P-388 leukaemia 
mouse. 
 
The antifeedant activity was noticed from the isolated 11,13-dihydrovernorodeline, this 
can resist insects from feeding on the plant but does not result in lethality (Yeap et al., 
2010). Vernolepin had also been reported to show antiplatelet property against ADP, 
arachidonic acid and collagen-induced platelet aggregation in rabbits (Erasto et al., 
2006; Yeap et al., 2010). Similar to other isolated sesquiterpenes lactones, vernomenin 
inhibited L-1210 cancer cell lines and P-388 leukaemia mouse (Jisaka et al., 1993; Yeap 
et al., 2010). 
 
Triterpenoids  
Triterpenoids are widely distributed in medicinal and edible plants. This phytochemical 
group is being evaluated for use in new functional foods, cosmetics, foods, and 
healthcare products. They have been isolated from the leaf, root and stem of V. 
amygdalina. They possess diverse pharmacological properties including anticancer, 
anti-inflammatory, hepatoprotective, antioxidant, antibacterial, antileukaemia, analgesic 
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and anti-nociceptive (Igile et al., 1994; Alabi et al., 2005; Nwaoguikpe, 2010; Yeap et 
al., 2010; Wong et al., 2013).  Some of the isolated triterpenes are thiamine, ascorbic 
acid, pyridoxine, glycine, cysteine, casein hydrolysate, eucalyptol, beta piene, myrtenal, 
and alpha-muurolol (Figure 2c). 
 
3.0 PHARMACOLOGICAL EFFECTS OF V. amygdalina 
V. amygdalina had been reported to possess several pharmacological effects like 
antimicrobial, antimalarial, antithrombotic, antioxidant, anti-diabetic, laxative, 
hypoglycemic, antihelmintic, anti-inflammatory, cathartic, anticancer, antifertility, anti-
fungi, antibacterial, and among others (Igile et al., 1994; Akinpelu, 1999; Iwalokun et 
al., 2006; Erasto et al., 2007; Gresham et al., 2008; Khalafalla et al., 2009; Ilondu, 
2010; Farombi and Owoeye, 2011; Anibijuwon et al., 2012; Ngatu et al., 2012; 
Adetunji et al., 2013; Atangwho et al., 2013; Akinyele et al., 2014; Ezeadila et al., 
2015; Udochukwu et al., 2015; Alara et al., 2017c). 
 
Antioxidant Effect 
The crude extracts from V. amygdalina had been studied to possess an antioxidant 
property by scavenging the free radicals cells. The aqueous extracts from the leaf 
showed a significant reduction in the malondialdehyde levels of oxidative stressed 
streptozotocin-induced diabetic rats (Nwanjo, 2005). The leaves extracts had been 
examined to scavenge 75-99.3% DPPH radicals and 96.2-100% of the ABTS radicals 
(Erasto et al., 2007). The presence of flavonoids in the V. amygdalina extracts had been 
attributed to their antioxidant property (Igile et al., 1994; Ayoola et al., 2008; Farombi 
and Owoeye, 2011). In vivo biochemical analysis of V. amygdalina leaf extracts on the 
rats showed an appreciable increase in the level of the antioxidants, superoxide 
dismutase, catalase, glutathione, and malondialdehyde. In addition, daily administration 
of the extracts to rats resulted in the reduction of their lipid profile when compared to 
the control (Imaga and Bamigbetan, 2013). The chemopreventive effects of V. 
amygdalina extracts had been attributed to their ability to scavenge free radical cells, 
interfere with DNA binding of some transcription factors, and induced detoxification 
(Amodu et al., 2013). Moreover, the extracts from this plant had been found to inhibit 
bleaching B-carotene, lipid peroxidation induced by iron ion ascorbate in a rat liver 
microsomal preparation, and linoleic acid (Khalafalla et al., 2009; Yeap et al., 2010). 
  
Anti-diabetic Effect 
Diabetes mellitus has been associated with a fasting venous plasma glucose 
concentration higher than 7.8 mmol/l (140 mg/dl) 2 h after an oral ingestion of 75 g 
glucose equivalent or carbohydrate meal (Nwanjo, 2005; Letchuman et al., 2010; Jan 
Mohamed et al., 2015). Studies had shown that aqueous extracts from V. amygdalina 
leaves reduced the blood glucose, increased the serum triglyceride levels and serum 
MDA, increased the LDL-cholesterol, and normalized cholesterol concentrations in 
streptozocin-induced diabetic rats (Nwanjo, 2005). In another study on the effect of V. 
amygdalina leaf extracts on blood glucose of diabetic rats, the results showed that 
decrease in blood glucose after administration of the extracts may be associated with the 
presence phytochemicals, vitamins and other nutrients in the extracts (Osinubi, 2008; 
Nwaoguikpe, 2010; Ejike et al., 2013). The aqueous extracts had been administered to 
alloxan-diabetic rats, the blood glucose and serum triglyceride levels were significantly 
reduced (Akah et al., 2004). Justin et al. 2012 had reported that decoction of V, 
amygdalina and Azadirachta indica leaves promptly lowered blood glucose and 
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maintained a relatively steady level over the study period. Likewise, the study on the 
activities of V. amygdalina leaves aqueous extracts on the haemostatic, haematological 
and biochemical profile of induced male diabetic albino rats showed a significant 
reduction in the glucose level (Oguwike et al., 2013). 
 
Anti-allergic Effect 
The extracts from V. amygdalina leaves had been reported to inhibit and prevent atopic 
or eczema dermatitis syndrome in mice (Ngatu et al., 2012). 
 
Anti-inflammatory Effect 
V. amygdalina leaves extracts had been reported to possess anti-inflammatory activity 
when applied to the ear of rat suffering from inflammation. It produced a significant 
reduction when compared with the application of acetylsalicylic acid (Georgewill and 
Georgewill, 2010). The percentage of inhibition of leaves extracts was higher than roots 
extracts (Egharevba et al., 2014). 
 
Anticancer Effect 
Breast cancer has been the second leading cause of deaths of women in the world 
(American Cancer Society, 2016). V. amygdalina leaves extracts had been reported to 
inhibit the proliferation of MCF-7 and MDA-MB-231 which involved the stimulation of 
cell-type specific G1/S phase cell cycle arrest in only MCF-7 cells but not in MDA-
MB-231 cells given an approximate of 70% of diagnosed breast cancer express ER-α 
(Opata and Izevbigie, 2006; Gresham et al., 2008; Wong et al., 2013). Owoeye et al. 
2010 had also reported the presence of epivernodalol in the methanolic extract of V. 
amygdalina leaf which was active against HT-144 (skin melanoma) cell line. On the 
other hand, the aqueous extracts were administered to mice for 4 weeks at dose 10 to 
100 µg/ml per day, there was a significant reduction in CYP1A2 expression. Methanol 
and chloroform extracts were as well inhibited human leukaemia monocyte THP-1 cell 
line with IC50 values of 19.1 and 243.4 µg/ml, respectively (Yeap et al., 2010).  
 
Antimicrobial Effect 
The aqueous and ethanol extracts of V. amygdalina leaves had shown antimicrobial 
effects against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, 
Klebsiella spp., and Candida albicans with the MIC values ranged between 12.5 and 50 
mg/ml (Ghamba et al., 2014). In another study, ethanolic and aqueous extracts of V. 
amygdalina leaves had shown a higher value of MIC inhibitions on Streptococcus 
mutans at 25 and 55 mg/ml, respectively (Akinpelu, 1999; Anibijuwon et al., 2012). 
 
Anti-malaria Effect 
Leaves and roots of V. amygdalina extract possessed antimalarial effect against drug 
sensitive Plasmodium berghei in mice which resulted in 67% and 53.5% suppression of 
parasitaemia after the four days of administration, respectively (Audu et al., 2012). The 
leaves extracts had exhibited a significant antiplasmodial effect in mice against 
Plasmodium berghei with 73% inhibition (Njan et al., 2008). In the same vein, isolated 
sesquiterpene lactones from V. amygdalina had been reported to show antiplasmodial 
property with IC50 < 4 µg/ml against Plasmodium falciparum (Egharevba et al., 2014). 
V. amygdalina leaf extracts dose had dependently restored the efficacy of chloroquine 
against Plasmodium berghei in mice which had developed resistance (Iwalokun, 2008). 
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Significant results were obtained antiplasmodial effects of ethanolic and aqueous 
extracts at IC50 values 44.03 and 41.690 µg/ml, respectively (Egharevba et al., 2014). 
 
Antifertility Effect 
The antifertility effect of 95% ethanolic extracts of V. amygdalina leaves on the isolated 
mouse uterus had been reported at doses of 0.385, 0.5, and 1.0 g/kg body weight of 
mice when compared with the control agonist acetylcholine (1 g/kg). Significant 
reduction in a mean number of implantation sites, the number of live foetuses and 
survival percentage were recorded (Egharevba et al., 2014). 
 
Antifungal Effect 
Sesquiterpene lactones had been known to be highly antifungal (Barrero et al., 2000; 
Wedge et al., 2000). The presence of vernodalol and vernolide which belongs to 
sesquiterpene lactones in the V. amygdalina leaves extracts made them exhibit higher 
antifungal effect against Penicillium notatum and Aspergillus flavus with LC50 values of 
0.4 mg/ml each (Erasto et al., 2006). 
 
Antibacterial Effect 
Sesquiterpene lactones from V. amygdalina leaves had exhibited antibacterial against 
five gram-positive bacteria with the MIC value of 0.25 mg/ml, but lack efficacy against 
gram-negative bacteria (Erasto et al., 2006). Likewise, the ethanolic stem extracts 
inhibited antibacterial effect against Staphylococcus aureus with 50 mg/ml 
concentration (Akinyele et al., 2014). The aqueous, ethanolic and methanolic extracts of 
the leaves had been reported to exhibit strong potency against clinical bacteria: 
Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli (Alo et al., 
2012; Adetunji et al., 2013). 
 
Anti-leukaemia Effect 
The root culture of cold water, hot water, and ethanolic V. amygdalina extracts had been 
tested on the patients suffering from acute leukaemia and myeloid leukaemia. The 
extracts showed a higher level of anti-leukemia activity on the patients (Khalafalla et 
al., 2009). 
 
4.0 MECHANISM OF ACTIONS OF V. amygdalina EXTRACTS 
V. amygdalina leaves extracts had been reported to possess protective effect against 
carbon tetrachloride-induced hepatotoxicity by the antioxidant mechanism of action 
(Adesanoye and Farombi, 2010). Whereas, the administration of V. amygdalina aqueous 
extracts to wistar rats showed a dose-dependent improvement on CD4+ cells in 
comparison to control group. It was suggested that the mechanism could be related to 
the presence of antioxidant bioactive compounds (saponins, tannins, and flavonoids). 
Another possible mechanism of action could be due to early maturation and release of 
leucocytes (Momoh et al., 2010). Therefore, the used of V. amygdalina leaf aqueous 
extracts were suggested as an immune booster in related health conditions (Egharevba 
et al., 2014). 
 
5.0 TOXICOLOGY OF V. amygdalina 
The toxicology of V. amygdalina leaves extracts had been studied on mice and the 
results showed no clinical signs of toxicity or toxicological effects in the treated groups, 
except for a significant decrease in red blood cell count and a dose-dependent increase 
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in serum bilirubin (Njan et al., 2008). Owen et al. 2011 had also reported that there was 
no indication of toxicity in the V. amygdalina leaves extracts upon biomolecules 
evaluations when administered to broiler finisher chickens. Likewise, there was no 
appreciable difference in the glucose level, haematological profile, liver, and kidney 
function of the tested rats when the extracts were administered to rats (Imaga and 
Bamigbetan, 2013). Egharevba et al. (2014) reported that the toxicity limit was 
insignificant when compared with the highly toxic substances (toxicity at less than 1 
mg/kg). Studies on the acute toxicity of the leaf extracts resulted in LD50 of 5.1523 g/kg 
when administered orally and this showed that the extracts were non-toxic (Adiukwu et 
al., 2012). In contrary, Temma people of Sierra Leone called bitter leaf as ‘goat killer’, 
this makes the animals to stay away from it due to its bitterness (Yeap et al., 2010). 
Table 3 shows some of the in vivo and in vitro toxicity of V. amygdalina. 
 
Table 3: In vivo and in vitro toxicology of Vernonia amygdalina 
Animal Type of 
extract 
LD50 (mg/kg 
b.w.) 
Mode of 
administration 
Consequences Reference(s) 
Rabbit Aqueous 1122 Intra-peritoneal 
injection 
- Akah and 
Okafor 
(2006) 
Rat Methanol 
leaf 
extract 
(28 days 
at 
doses of 
80, 
160 and 
320 
mg/kg) 
 
 
Chlorofor
m 
fraction 
(7-14 
days at 55 
mg/kg 
b.w.) 
 
Ethanol 
(dosage at 
40 
mg/kg) 
 
Aqueous 
of 
combined 
V. 
- 
 
 
 
 
 
 
 
 
 
 
 
 
- 
 
 
 
 
 
 
 
- 
Intravenous 
injection 
 
 
 
 
 
 
 
Intra-peritoneal 
injection 
 
 
 
Intra-peritoneal 
injection 
 
 
Oral 
The 
histopathologic
al studies 
showed no 
significant 
abnormalities 
in all the vital 
organs of the 
rats. 
 
No effect on 
glycolysis 
 
 
 
- 
 
 
 
Any apparent 
toxic symptom 
or mortality 
was not 
observed after 
the 24 h 
 
Akah et al. 
(2009) 
 
 
 
 
 
 
 
Atangwho et 
al. (2014) 
 
 
 
 
Asante et al. 
(2016) 
 
Mansurah et 
al. (2013) 
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amygdali
na and O. 
gratissim
um (24 h 
at doses 
from 10-
5000 
mg/kg) 
Broiler 
finishers’ 
Leaf meal 
(28 days 
using 0%, 
5%, 10% 
and 15% 
VALM) 
 
- Mixed with 
broilers’ meals 
The leaf meals 
have no 
adverse effect 
on the kidney, 
since the 
creatinine 
levels were not 
significantly 
altered. 
 
Owen (2011) 
Murine 
macrophages 
J774 
Lipophili
c extract 
IC50 value of 
6.48 µg/ml 
- - Ganfon et al. 
(2008) 
Guinea pig Aqueous 
(0.3 
mg/ml) 
Injection - Increase of 
uterine, 
intestine and 
jejunum 
contraction 
which 
sustained for 
30 min with 
elevated 
concentrations 
used 
Yeap et al. 
(2010) 
Albino mice Aqueous 
(7 days at 
doses of 
125 
mg/kg) 
- Intra-peritoneal 
injection 
 
Increase of 
serum enzyme 
markers level 
was more 
severe when it 
was 
consumed with 
antimalarial 
drug 
chloroquine 
Iwalokun 
(2008) 
 
6.0 CONCLUSION 
This review reveals that V. amygdalina is endowed with different bioactive compounds 
that possess several pharmacological properties. Its medicinal potential has been 
explored, proven very effective with no toxicity to health. V. amygdalina is an 
ethnomedicinal plant that may be used in managing tropical diseases. However, other 
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pharmacological properties of this plant abound which can require genetic evaluation. 
In addition, several works had been carried out on the phytochemical, pharmacological 
properties, toxicology and mechanism of action of V. amygdalina leaf but few studies 
had been done on the stems and roots. Therefore, further studies are required to isolate 
and validate the potential of the V. amygdalina stems and roots. 
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